Residual Risk Despite High Short Physical Performance Battery Scores in Older Patients With Heart Failure: A Multicenter Retrospective Cohort Study.
Key claim: Older heart failure patients with high physical performance scores (SPPB ≥10) still face significantly increased 1-year adverse outcome risks if they have impairments in grip strength, chair stand performance, or calf circumference.
Abstract
BACKGROUND: The prognostic value of the Short Physical Performance Battery (SPPB), which is widely used to assess physical function and prognostic risk in patients with heart failure (HF), is unclear in patients with high SPPB scores. In this study we evaluated whether sarcopenia-related factors defined by the Asian Working Group for Sarcopenia in 2019 provided additional prognostic value in this population. METHODS AND RESULTS: This retrospective multicenter cohort study of the J-Proof HF registry included 3,044 patients aged ≥65 years with a discharge SPPB score ≥10. Impairments in handgrip strength, five-times chair stand test, and calf circumference were aggregated into a composite physical function score (range, 0-3). The primary outcome was the composite of all-cause death or rehospitalization for HF within 1 year, which occurred in 25.0% of the cohort. The composite outcome risk increased in a stepwise manner with each additional impaired domain (adjusted hazard ratio per 1-point increase, 1.245; 95% confidence interval 1.132-1.370; P<0.001). The fully adjusted model showed acceptable discrimination (Harrell’s C-index=0.694). Each domain independently demonstrated a similar magnitude of association with the outcome. CONCLUSIONS: Even among older patients with HF and preserved physical performance (SPPB ≥10), accumulation of sarcopenia-related impairments was associated with an increased risk of adverse outcomes. Supplementing the SPPB with simple functional assessments may improve risk stratification in clinical practice.
Why this matters
[human-observational] In older patients with heart failure, sarcopenia-related measures identified residual 1-year adverse-outcome risk even among those with high SPPB scores, showing that a favorable composite functional score can mask prognostically relevant impairments. [human-observational] This finding concerns outcome prediction in a specific clinical population, not evidence that changing a functional score changes aging or prevents adverse outcomes.